ROCKVILLE, MARYLAND, August 31, 2022 – BioHealth Innovation Inc. (BHI) is pleased to welcome Olivia Meyer, M.S., as a new Life Sciences Business Analyst at the NIH Office of Extramural Research. Olivia will be evaluating the commercial potential of emerging technologies and providing recommendations on go-to-market strategies.
Olivia graduated with her Master’s in Biotechnology from Northwestern University and Neuroscience & Physiology Bachelor’s of Science from the University of California, San Diego. She has been working in the biotechnology industry since 2015 in content creation and strategic marketing. Olivia has worked with Illumina, United Biochannels, Cisco, and on various consulting projects at smaller biotechnology companies.
“BHI is pleased to welcome Olivia to the team,” said Richard Bendis, BHI President and CEO. “Her education in biotechnology and industry experience will provide value to both BHI and our partners at the NIH Office of Extramural Research.”
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc. (BHI) is a public-private nonprofit organization focused on accelerating biohealth (therapeutic, diagnostic, medtech, and health IT) commercialization in the BioHealth Capital Region (Maryland, DC, and Virginia).
www.BioHealthInnovation.org
# # #
Media contacts:
Rich Bendis
Phone: 301-637-6439, email: rbendis@biohealthinnovation.org